Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI
· Real-Time Price · USD
16.72
0.41 (2.51%)
At close: Oct 16, 2025, 3:59 PM
16.40
-1.91%
After-hours: Oct 16, 2025, 07:25 PM EDT
2.51% (1D)
| Bid | 12.4 |
| Market Cap | 2.44B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -479.03M |
| EPS (ttm) | -2.81 |
| PE Ratio (ttm) | -5.95 |
| Forward PE | -5.45 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 20.99 |
| Volume | 2,448,005 |
| Avg. Volume (20D) | 1,936,859 |
| Open | 16.49 |
| Previous Close | 16.31 |
| Day's Range | 16.30 - 17.39 |
| 52-Week Range | 10.57 - 33.33 |
| Beta | 1.29 |
| Ex-Dividend Date | n/a |
About DNLI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DNLI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DNLI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsDenali Therapeutics Inc. is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 months ago
+11.8%
Denali Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
7 months ago
-8.21%
Denali Therapeutics shares are trading lower after Oppenheimer cut its price target on the stock from $50 to $42.
